Skip to content

A Comparative Clinical Study to Evaluate the Effect of Trutyadi Churna tablet with Pashanabheda Kashaya Ghana Tablet and Trutyadi Churna tablet in the Management of Cholelithiasis

EFFICACY OF TRUTYADI CHURNA TABLET WITH PASHANABHEDA KASHAYA GHANA TABLET IN COMPARISION TO TRUTYADI CHURNA TABLET IN THE MANAGEMENT OF CHOLELITHIASIS - AN OPEN LABEL RANDOMIZED CLINICAL STUDY - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102435
Enrollment
30
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis

Interventions

None listed

Sponsors

SDM COLLEGE OF AYURVEDA HOSPITAL AND RESEARCH CENTRE UDUPI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of Cholelithiasis as per the diagnostic criteria Subjects with gallstones measuring less than 10m Subjects who are willing and able to provide informed consent.

Exclusion criteria

Exclusion criteria: Subjects during the phase of Biliary colic. Subjects in whom Kshara is contraindicated. Subjects with gallstones associated with complications, such as acute obstructive cholecystitis, acute pancreatitis, liver failure, Congenital anomalies of the gallbladder, Calcified gallbladder, carcinoma of gall bladder and other pathological conditions presenting signs of jaundice Immune-compromised subjects Subjects suffering from other systemic disorders which might hamper the efficacy of the given treatment. Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
TRANSABDOMINAL USG 1) Reduction in size of the stones: Grade 0 = 0% Grade 1 = 25% Grade 2 = 50 % Grade 3 = 75% Grade 4 = 100% 2) Reduction in number of stones: Grade 0 = 0% Grade 1 = 25% Grade 2 = 50% Grade 3 = 75% Grade 4 = 100%Timepoint: 0th and 60th Days

Secondary

MeasureTime frame
1) Pain in the right upper abdomen 2) Pain below the right shoulder 3) Nausea 4) Vomiting 5) Flatulence, Dyspepsia 6) Recurrent IndigestionTimepoint: 0th, 60th and 90th day

Countries

India

Contacts

Public ContactDr Shailesh Y

SDM COLLEGE OF AYURVEDA UDUPI

drshayayu@gmail.com9481522560

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026